Patients on uremic dialysis who develop sarcopenia require nutritional support, medication, exercise therapy, and psychotherapy.
It is important to supplement protein for patients on dialysis because protein is an important component of muscle, and supplementation of high-quality protein and essential amino acids can promote skeletal muscle protein synthesis, which is beneficial to the prevention of sarcopenia.
To treat sarcopenia in patients with uremia, medication should be applied in moderation. Commonly used medications include vitamin D, sodium bicarbonate, angiotensin II receptor blockers (irbesartan, timosartan, etc.) and other medications, and some patients need hormone therapy, such as testosterone, estrogen, and so on.
Exercise therapy as well as psychotherapy for sarcopenia is also important. Exercise therapy includes aerobic exercise, resistance exercise and combined exercise. It is also important to pay attention to the patient’s psychological state, such as improving the patient’s anxiety and depression, which can help the recovery of myasthenia gravis.
Uremic dialysis patients with complications of myasthenia gravis should go to a regular hospital in time and receive standardized treatment under the guidance of a specialist. Drugs need to be used in accordance with medical advice, do not self-medicate.